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Summary
The dorsoventral axis of the Drosophila embryo is
patterned by a gradient of bone morphogenetic pro-
tein (BMP) ligands. In a process requiring at least
three additional extracellular proteins, a broad do-
main of weak signaling forms and then abruptly
sharpens into a narrow dorsal midline peak. Using ex-
perimental and computational approaches, we inves-
tigate how the interactions of a multiprotein network
create the unusual shape and dynamics of formation
of this gradient. Starting from observations suggest-
ing that receptor-mediated BMP degradation is an im-
portant driving force in gradient dynamics, we de-
velop a general model that is capable of capturing
both subtle aspects of gradient behavior and a level
of robustness that agrees with in vivo results.
Introduction
Patterning of the dorsal-ventral axis of the Drosophila
embryo is initiated by a nuclear gradient of the mater-
nally deposited transcription factor Dorsal (Rusch and
Levine, 1996), which activates expression of neuroec-
todermal genes such as short gastrulation (sog) (Fran-
cois et al., 1994; Markstein et al., 2002) in ventrolateral
regions of the embryo, and nonneurectodermal genes
such as decapentaplegic (dpp), tolloid (tld), and twisted
gastrulation (tsg) in dorsal cells. By the midblastoderm
stage, these zygotically active genes initiate a further
round of patterning events, which lasts from the mid-
cellular blastoderm stage through the beginning of gas-
trulation. During this time, the dorsal region of the
embryo is subdivided into at least two distinct do-
mains: an extraembryonic cell type known as amnioser-
osa (dorsal-most cells) and epidermal ectoderm (the
ventral portion of the nonneural ectoderm). In the dor-
sal region, a variety of genes are expressed in nested
patterns centered on the dorsal midline, in a process
that reflects graded signaling by the bone morphoge-
netic protein (BMP) pathway (Ashe et al., 2000; Jazwin-
ska et al., 1999; Ray et al., 1991; Wharton et al., 1993).*Correspondence: adlander@uci.edu (A.D.L.); ebier@ucsd.edu (E.B.)Activation of the BMP pathway in Drosophila em-
bryos can be visualized directly, using immunohisto-
chemistry to detect the phosphorylated form of the cy-
toplasmic protein Mad. Phosphorylated Mad (PMad)
accumulates as a direct consequence of BMP receptor
activation and translocates into the nucleus of re-
sponding cells (Dorfman and Shilo, 2001; Maduzia and
Padgett, 1997; Raftery and Sutherland, 1999; Ross et
al., 2001; Rushlow et al., 2001; Sutherland et al., 2003),
where it acts as a transcriptional cofactor (Wotton and
Massague, 2001). PMad is initially detected in a fairly
broad and shallow pattern during midblastoderm stages,
but then refines to a relatively sharp stripe of 5–7 cells
at the dorsal midline (Dorfman and Shilo, 2001; Ross et
al., 2001; Rushlow et al., 2001; Shimmi and O’Connor,
2003). Establishing this peak of PMad staining requires
the function of at least four extracellular proteins be-
sides Dpp itself: Sog (an antagonist of BMP signaling
[Ferguson and Anderson, 1992; Francois et al., 1994;
Yu et al., 1996]), Tsg (which binds to Sog and Dpp to
form a trimeric inhibitory complex [Chang et al., 2001;
Mason et al., 1994; Mason et al., 1997; Ross et al., 2001;
Scott et al., 2001; Yu et al., 1996]), Tld (a protease that
cleaves Sog [Marques et al., 1997; Shimell et al., 1991;
Shimmi and O’Connor, 2003]), and Scw (another BMP
ligand that increases the activity of Dpp [Arora et al.,
1994; Nguyen et al., 1998]). The relationship between
PMad staining and the expression of genes in broader
dorsal patterns presumably reflects different threshold
levels of BMP response (Ashe et al., 2000; Rushlow et
al., 2001).
Ever since it became apparent that both Sog and Tsg
can act as inhibitors of BMP activity, investigators have
found it puzzling that loss of function of either of these
molecules eliminates the peak of strong BMP signaling
activity at the dorsal midline (Decotto and Ferguson,
2001; Harland, 2001; Holley et al., 1996; Ray and Whar-
ton, 2001). How can antagonists be responsible for ele-
vating the activity of the molecule they inhibit? To ex-
plain this seeming paradox, it has been suggested that
Sog plays two roles in creating the BMP activity gradi-
ent. First, because it is present in a graded distribu-
tion—diffusing from lateral neural ectoderm to form a
protein gradient in the dorsal ectoderm (Srinivasan et
al., 2002)—Sog sets up a gradient of BMP inhibition
from ventral to dorsal, limiting the ventral extent of BMP
signaling. The view that Sog acts in this fashion is sup-
ported by the finding that domains of BMP target gene
expression increase in width ventrally by several diam-
eters in sog−/+ heterozygous embryos (Biehs et al.,
1996) and expand to occupy most of the dorsal ecto-
derm in sog null embryos (Francois et al., 1994; Ray et
al., 1991). Second, Sog has been proposed to bind
BMPs and carry them dorsally, causing their accumula-
tion at the dorsal midline (Holley et al., 1996). This role
of Sog in BMP transport could then explain the greater
levels of BMP signaling at the dorsal midline in wild-
type versus sog null embryos (Ross et al., 2001;
Rushlow et al., 2001). This ability of Sog to elevate BMP
signaling at a distance from the site of Sog expression
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are expressed at ectopic locations, studies that further e
demonstrate a requirement for Tld in this process (Ashe b
and Levine, 1999). Thus, the transport function of Sog c
has been viewed as a “shuttle,” in which BMPs bind a
Sog, diffuse dorsally, and are then liberated in an active C
form by Sog cleavage (Ashe, 2002; Eldar et al., 2002; i
Meinhardt and Roth, 2002; Shimmi and O’Connor, i
2003). In the case of Tsg, genetic and biochemical p
studies suggest that it is an essential cofactor in the s
binding of Dpp to Sog, thus participating in both the o
inhibitory activity of Sog as well as its transport func- (
tion (Scott et al., 2001; Shimmi and O’Connor, 2003). m
Given that crucial extracellular components involved t
in regulating BMP signaling in the early Drosophila l
embryo have been identified, and the time course of o
BMP activation can be followed by examination of
PMad activation and expression of dosage-sensitive
BMP target genes, this system is particularly amenable D
to quantitative analysis. Here we undertake such an B
analysis, beginning with a critical evaluation of several a
key properties (morphogen diffusibility, stability) and (
performance objectives (robustness) of the dorso- c
ventral patterning system. We provide experimental f
evidence that Dpp is readily diffusible in the embryo m
(whether or not Sog is present) and that patterning a
does not exhibit the high degree of robustness (lack of W
sensitivity to changes in sog dosage) that others have i
asserted (Eldar et al., 2002). We show that a relatively w
simple computational model, in which receptor-medi- d
ated morphogen degradation plays a central role, cap- e
tures the Sog-dependent shuttling of BMPs to the mid-
a
line and provides insights into the unusual dynamics of
7this gradient-forming process.
m
mResults
t
The BMP Activity Gradient Is Not Robust with
dRespect to Changes in sog Gene Dosage
cThe fact that Drosophila embryos heterozygous for mu-
wtations in sog, tsg, tld, or scw develop into apparently
enormal adults (dpp, in contrast, is haploinsufficient [Irish
eand Gelbart, 1987]) suggests that the embryonic BMP
esignaling gradient is highly robust. However, several
tobservations indicate otherwise. For example, expres-
(sion of BMP target genes in the dorsal region of the
dembryo is sensitive to sog gene dosage (Biehs et al.,
1996), and heterozygosity for sog can rescue the lethal-
mity caused by dpp haploinsufficiency (Francois et al.,
l1994) as well as that associated with a hypomorphic
rallele of tld (Ferguson and Anderson, 1992). The dataFigure 1. The Distribution of PMad in Dorsal
Cells Is Dependent on Sog Dosage
PMad staining in embryos at late blastoderm
stage of the following genotypes: (A) wt (two
copies of sog), (B) sog−/+ (one copy of sog),
and (C) w/Dp(1;Y)sog+ (equivalent to four
copies of sog). The dorsal PMad stripe spans 5–6 cells in wt embryos (A), whereas in the sog−/+ embryo (B) it becomes twice as wide (10–13
cells). Conversely, an extra dosage of Sog leads to decreased levels of PMad and interruptions in the stripe (asterisk). Bars indicate the width
of PMad expression and insets show Nomarski cross-sections of embryos that have completed cellularization. Mutant embryos in (B) and
(C) were collected from w females crossed to sog6/Dp(1;Y)sog+ males carrying a duplication of sog on the Y chromosome. All resulting female
embryos are sog−/+ while male embryos are w/Dp(1:Y)sog+. The two classes were unambiguously identified by double-labeling with an
antibody against the female-specific Sex-lethal protein (not shown). For each of the genotypes shown, at least 20 embryos were examined.
Within any given genotype, variability of only about 1–3 cells was observed in the widths of PMad stripes, i.e., a level much smaller than the
observed differences between genotypes.in Figure 1 clearly show, in embryos of unambiguousenotype, that changes in sog gene dosage have large
ffects on the dorsal PMad stripe at the final stage of
lastoderm. In wild-type females, this stripe is w5–6
ells across (Figure 1A), whereas in sog−/+ females, it is
pproximately twice as wide (10–13 cells; Figure 1B).
onversely, when the sog dose is increased (two cop-
es of sog in males or three in females), PMad staining
s reduced in both breadth and intensity, with gaps at
oints along the midline (Figure 1C). These changes are
ufficient to explain the ventrally expanded expression
f BMP target genes in sog−/+ heterozygous embryos
Biehs et al., 1996). The fact that sog−/+ animals ulti-
ately develop normally must therefore reflect regula-
ion at later stages. Accordingly, marked robustness, at
east with respect to sog dosage, is not a characteristic
f the embryonic BMP gradient.
pp Acts at a Distance Even in the Absence of sog
MPs are soluble in vitro, and previous studies on Dpp
ction in wing discs suggest unhindered BMP diffusion
Lander et al., 2002; Teleman and Cohen, 2000). This
ontrasts with the recent assertion that, to be able to
orm an appropriate gradient in the embryo, free BMPs
ust diffuse at least 100 times slower than BMPs that
re in complex with Sog and/or Tsg (Eldar et al., 2002).
e sought to investigate the in vivo diffusivity of BMPs
n both the presence and absence of Sog. To do this,
e expressed Dpp in various mutant backgrounds un-
er the control of the even-skipped (eve) stripe 2 (st2)
nhancer, and we measured ranges of gene induction
nd Mad phosphorylation relative to the endogenous
-stripe eve expression pattern. Multilabeling in situ
ethods (Kosman et al., 2004) allowed us to compare
ultiple gene expression patterns within single, geno-
yped embryos.
In wild-type embryos with two copies of st2-dpp, the
orsal PMad stripe broadens to a maximum of 15–16
ells in the vicinity of st2, thinning back to its normal
idth posteriorly (Figures 2A and 2B). By the time the
ndogenous PMad stripe has refined (stage 6/7), the
xpansion of PMad activation extends back to between
ve-stripes 5 and 6, a distance of w25–30 cell diame-
ers (Figure 2B). A similar effect on expression of race
a high-threshold dpp target gene) was observed in st2-
pp embryos (Figure 2D).
We then measured the effects of st2-dpp in a sog−
utant background. Since race expression is normally
ost in most of the trunk and is maintained only in the
egion anterior to eve-st2 in sog− mutant embryos(Ashe and Levine, 1999; also compare Figures 2C and
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Absence of Sog
Dorsal view of blastoderm-stage embryos
doubly stained for eve mRNA and either
PMad (A and B) or race (C–F; in situ hybrid-
ization probes are indicated in the lower right
corner of each figure). eve serves as a
marker to measure distances along the AP
axis between the st2 site of dpp expression
and the range of ectopic PMad or race acti-
vation (indicated by the horizontal bars in
[B], [D], and [F]).
(A) Dorsal PMad stripe in a wild-type (wt)
embryo.
(B) sog+ embryo carrying two copies of st2-
dpp. The PMad stripe in st2-dpp embryos
assumes a bottle-like shape, which is
broader nearest to the st2-dpp, tapering pro-
gressively further from the Dpp source, until
regaining its normal width posterior to eve-
st6 (compare vertical bars in [A] and [B]).
Significant ectopic PMad activation extends
to between eve stripes 5–6.
(C and D) A similar effect is observed on the
Dpp target gene race, as shown. (C) Normal
race pattern in a wt embryo, and (D) race expansion in a sog+; st2-dpp embryo also extends to eve-st6 (bracket).
(E and F) Dpp range of action was also measured in the absence of Sog by the ectopic activation of race by st2-dpp. In sog− embryos, race
expression is ordinarily restricted to the head (E, bar). Ectopic expression of st2-dpp in a sog− background leads to a significant long distance
activation of race, which extends to between eve stripes 4–5 (bars).2E), any posterior race signal in sog−; st2-dpp embryos
must come from the action of Dpp produced at st2.
We find substantial posterior race expression in such
embryos, extending to between eve-stripes 4 and 5
(Figure 2F). These results indicate that Dpp can act over
15–20 cell diameters in a sog− background. A similar
analysis of the range over which st2-dpp inhibits ex-
pression of the neural gene ind reveals effects over
even greater distances (C.M. Mizutani et al., submitted).
Even when the spread of a morphogen is by diffu-
sion, the range over which it acts will be set by the
balance between diffusion and two other processes—
production and removal (i.e., receptor-mediated uptake
and degradation, as discussed in the next section). For
example, no matter how slowly a molecule diffuses,
one could achieve (in principle) as large a range of ac-
tion as one liked simply by expressing it at high enough
levels. To make sure that this effect did not account for
the long range of Dpp action we observed in Figure
2, we examined individual st2-dpp embryos by in situ
hybridization to compare dpp mRNA levels in eve-
stripe 2 with those in the dorsal region of endogenous
dpp expression outside of the st2-dpp domain. We
found that, in embryos with two copies of st2-dpp, dpp
expression within stripe 2 was only about 2.5- ± 0.7-
fold higher than endogenous dpp expression. This dif-
ference would have had to be much larger to explain
the range of action of st2-dpp, were Dpp only poorly
diffusible (see Supplemental Data available with this ar-
ticle online).
We also examined the range of Dpp action in mater-
nally lateralized embryos, which express no endoge-
nous Dpp. In these embryos, sog is expressed globally
throughout the neuralized ectoderm, and expression of
a single copy of eve st2-dpp has no detectable effects
(Figure 3A), presumably because Sog levels are high
enough to fully antagonize BMP signaling. In contrast,when sog is removed from such embryos (i.e., in latera-
lized sog−; st2-dpp embryos), PMad staining is ob-
served, which builds progressively to a domain 7–10
cells in either direction beyond the limits of eve2 ex-
pression (Figures 3B–3E). Thus, in a lateralized sog−
background, BMP activity also can spread a signifi-
cant distance.
BMP Degradation and the Dynamics
of Gradient Formation
In many morphogen systems, gradient formation is the
direct result of a balance between morphogen prod-
uction and morphogen degradation (Dubois et al.,
2001; Eldar et al., 2003; Lander et al., 2002; Teleman
and Cohen, 2000). Although little is known about BMP
degradation in the Drosophila embryo, results in the lar-
val wing disc argue that Dpp is rapidly turned over (Tel-
eman and Cohen, 2000). Effects of receptor overex-
pression (Lecuit and Cohen, 1998) suggest that Dpp
degradation in the disc is receptor driven (Lander et al.,
2005), which is consistent with in vitro evidence that
BMP binding triggers receptor-mediated endocytosis
(Jortikka et al., 1997).
Although the embryonic BMP signaling gradient is
much shorter lived (developing and acting over w1 hr;
Campos-Ortega and Hartenstein, 1985; Dorfman and
Shilo, 2001) than its counterpart in the larval wing disc,
we wondered whether BMP degradation might still play
an important role in gradient formation. Measuring BMP
degradation directly would be technically very difficult
in the Drosophila embryo. Nevertheless, we can infer
from experimental data that it must take place. For ex-
ample, in Figure 3B, Dpp was expressed under the con-
trol of the eve st2 enhancer for a continuous period of
about 45 min, in the absence of any Sog or endogenous
Dpp. By fixing embryos at various times, we observed
that levels of PMad staining evolved rapidly to a stable,
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Absence of Sog Was Assayed by PMad Ex-
pression in Lateralized Embryos with Uni-
form Levels of Dorsal
Mutant embryos were derived from sogU2
gd7/ gd7; Tl3/+ crossed to st2-dpp males. In
this case, endogenous dpp expression is ab-
sent and st2-dpp (one copy) is the only source of Dpp. In this lateralized background, sog is ubiquitously expressed (A), which in turn blocks
Dpp activity in the vicinity of st2-dpp and results in no PMad staining except at the poles (arrows). Removal of sog (B–E) leads to ectopic
activation of PMad in a stripe that is more than twice as wide as the st2-dpp stripe ([B], bars; [C]–[E] are higher-magnification views of the
embryo in [B]).unchanging pattern by about 30 min (data not shown). t
oIn the face of continuous Dpp production, if Dpp degra-
dation were not occurring, PMad staining should con- t
ltinue to expand indefinitely outward from the Dpp
source (Lander et al., 2002). S
DThe fact that a steady pattern is reached within 30
min allows us to estimate the rate of Dpp degradation.
gThis is because the system created by st2-dpp expres-
sion in a lateralized sog− embryo matches a simple t
pmorphogen diffusion problem that we have previously
analyzed (a stripe of morphogen production feeding a p
ofield of cells in which only diffusion and receptor-medi-
ated binding and degradation take place [Lander et al.,
2002; Lander et al., 2005]). To a first approximation, the
approach to steady state of such a system is set by the
time constant of degradation itself. Thus, a pattern that
has reached two-thirds of its steady-state value by 35
min implies a degradation rate constant of at least 5 ×
10−4 s−1. This is in the same range as the rate constant
for Dpp degradation in the wing disc, estimated as
R2 × 10−4 s−1 (Lander et al., 2002; Teleman and Cohen,
2000). Given the existence of a rapid degradative path-
way, it makes little sense to ignore its potential influ-
ence on the establishment of the embryonic BMP gra-
dient.
Creating a Dorsal Midline Peak Does Not Place
Limits on BMP Diffusivity
The ability to create a sharp peak of morphogen activity
at the dorsal midline is a remarkable feature of the em-
bryonic BMP gradient. We wondered what roles robust-
ness, BMP diffusivity, BMP degradation, and other phe-
nomena played in the formation of such a peak. We
therefore produced a simple computational model (Fig-
F
ure 4): within the geometry of the perivitelline space of M
the Drosophila embryo, Dpp, Sog, and Tsg are continu- M
ously produced in the appropriate places (the dorsal L
half of the embryo for Dpp and Tsg; the ventral half for a
dSog) at constant rates from a starting concentration of
tzero. Receptors are assumed to be at constant concen-
atration everywhere and to continuously degrade bound
LBMPs. Dpp-Sog-Tsg complexes assemble and are then
a
degraded at a constant rate by Tld to liberate free Dpp i
and Tsg. All secreted molecules are assumed to be n
mfreely diffusible, and Sog functions simply as a compet-
aitive inhibitor of Dpp binding to its receptor (another
odeparture from the Eldar et al. [2002] model, which re-
wquired Sog to displace Dpp from its receptors). We con-
f
sidered only a single BMP ligand (Dpp) rather than two u
independent ones (Dpp and Scw) for two reasons. First, v
sour main goal was to identify the minimal conditionsf Mad phosphorylation that quickly develops at about
igure 4. Partial Differential Equations Describing a “Minimal”
odel of Gradient Formation Driven by Diffusion and Receptor-
ediated Ligand Degradation
= BMP ligand (e.g., Dpp); R = receptor; S = Sog; T = Tsg; VL, VS,
nd VT are production rates and DL, DS, and DST; DT and DLST are
iffusion coefficients for their subscripted species; and associa-
ion, dissociation, and degradation rate constants for L-R binding
re represented by kon, koff, and kdeg, respectively. The assembly of
ST complexes is modeled as initial S-T binding (with association
nd dissociation rate constants jon and joff) followed by L-ST bind-
ng (with association and dissociation rate constants of non and
off), but analysis and calculations show that the output of the
odel is substantially the same for other assembly orders. In the
bsence of any data showing that free Sog and Tsg are degraded
ver the time course of embryonic patterning, these processes
ere generally not included (the effect of including degradation of
ree Sog [Srinivasan et al., 2002] was explored preliminarily, and
nless very rapid, did not substantially influence the model’s beha-
ior). Tolloid-mediated cleavage of LST complexes was repre-
ented by a single first-order rate constant, τ.hat could reproduce the basic shapes and dynamics
f the BMP gradient. Second, recent data suggest that
he major signaling molecule in vivo is, in fact, a single
igand—a Dpp/Scw heterodimer—that interacts with
og, Tsg, and Tld in the same ways as homodimeric
pp, but with different affinities (Shimmi et al., 2005).
As shown in Figure 5, even this simple system can
enerate a sharp activity peak at the dorsal midline of
he embryo in less than 30 min after the onset of Dpp
roduction (also see Supplemental Data). Such a
attern agrees with the biological observation of a peak
Origin of a BMP Activity Gradient
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the Dorsal Midline
For many parameter sets, an early phase with low level of BMP
activity broadly distributed across the entire dorsal region is fol-
lowed by the abrupt growth of a sharp midline peak. Parameters in
this case were DL = DS = DST = DT = DLST = 85 m2 s−1; VL = 1 nM
s−1 and limited to the dorsal region; VT = 4 nM s−1 and limited to
the dorsal region; VS = 80 nM s−1 and limited to the ventral region;
kon = 0.4 M−1 s−1; koff = 4 × 10−6 s−1; kdeg = 5 × 10−4 s−1; jon = 95
M−1 s−1; joff = 4 × 10−6 s−1; non = 4 M−1 s−1; noff = 4 × 10−5 s−1;
τ = 0.54 s−1; R0 = 3 M. The circumference of the embryo was taken
to be 550 m; with the dorsal midline set at x = 0, the dorsal half
may be defined as −137.5 < x < 137.5 m.30 min and then stabilizes (Dorfman and Shilo, 2001;
Sutherland et al., 2003). This behavior depends upon
the presence of Sog and its cleavage by Tld. In the
absence of Sog, the model predicts only a broad shal-
low peak of pMad activity (Figure 6A). The same picture in parallel, leading to a relatively fixed level of free Dpp.
Figure 6. Calculated Effects of sog, tld, and tsg Mutations on the BMP Activity Gradient
Unless otherwise indicated, gradients were calculated using the parameters in Figure 5, and patterns shown are at 38 min after the onset of
BMP production.
(A) Effects of sog gene dosage. The rate of Sog production was set to 0, 40, 80, or 160 nM s−1 to represent Sog−/−, Sog−/+, Sog+/+, and 2×
Sog animals, respectively. Increasing sog dosage generates a smaller, narrower peak, whereas decreasing sog dosage creates a broader
peak (cf. Figure 1).
(B) Effect of tld and tsg mutations. In the absence of Tsg, a broad flat domain of BMP signaling is seen in the dorsal half of the embryo,
similar to that in sog−/− mutants in (A). In the absence of Tld, BMP signaling is very low everywhere and exhibits no midline peak. These data
are consistent with the dorsalized and ventralized phenotypes of tsg−/− and tld−/− mutants, respectively.is seen in the absence of Tsg, whereas in the absence
of Tld, BMP signaling is very low everywhere (Figure
6B). These predictions agree with in vivo observations
(Mason et al., 1994; Ross et al., 2001; Shimmi and
O’Connor, 2003; Yu et al., 2000) and support the view
that a Sog/Tld-dependent BMP shuttling mechanism
(Decotto and Ferguson, 2001; Holley et al., 1996; Ross
et al., 2001; Shimmi and O’Connor, 2003) is responsible
for the initial production of a midline peak of signaling.
Apparently, such a mechanism can operate even if
there is only one kind of BMP ligand and even if that
ligand is freely diffusible, is produced continuously, and
undergoes rapid receptor-mediated degradation.
The model also predicts—in agreement with the data
in Figure 1—that the midline peak of BMP signaling will
be significantly wider in sog−/+ embryos and signifi-
cantly narrower and lower in embryos with an extra
dose of Sog (Figure 6A). Interestingly, the predicted in-
crease in peak width in sog heterozygotes is not as
large as that observed in vivo (Figure 1), even when
looked at over a wide range of parameter values (see
Discussion).
The dynamics of the growth of the midline PMad
peak in the model are intriguing. As shown in Figure 5,
no peak is seen for 15 min, then one abruptly rises over
the next 5–10 min. The abrupt appearance of a midline
peak matches in vivo observations, in which a midline
stripe of strong PMad immunoreactivity appears rather
suddenly between mid and late blastoderm stages
(Ross et al., 2001, cf. Figures 1I and 1J; C.M.M. and E.B.,
unpublished observations), an interval corresponding to
about 10 min (Campos-Ortega and Hartenstein, 1985).
Analysis of the model shows that the early “plateau
phase” of relatively constant, low PMad staining re-
flects a time when the Sog and Dpp concentrations rise
Developmental Cell
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dcauses the release of bound Dpp, which binds to and
causes the destruction of additional Sog, ultimately
dcreating a chain reaction that leads to rapid loss of free
Sog, and an abrupt jump in free and receptor bound t
SDpp. Interestingly, this dynamic behavior is not related
to the ventrodorsal shuttling of BMPs. Even if all mole- o
2cules were expressed everywhere in the embryo, one
would still see this “plateau-jump” behavior, although it g
twould occur everywhere at once, not just at the dorsal
midline (see Supplemental Data). D
2A second interesting feature of the model is that it
explains how reducing sog dosage can partially rescue p
pthe effects of reduced dpp dosage (Figure 7A). As men-
tioned earlier, embryos that are dpp−/+ are substantially b
Srescued from lethality by reduction in the dosage of sog
(Francois et al., 1994). The data in Figures 7B–7D show s
othat such rescue occurs at the level of the embryonic
PMad pattern (rather than through some later compen- e
asatory process). These experimental results are surpris-
ing because, individually, sog and dpp mutations act in m
athe same direction at the dorsal midline—they both
lower the intensity of the PMad peak and decrease t
tDpp-dependent gene expression (Biehs et al., 1996;
Rusch and Levine, 1996; Rusch and Levine, 1997). The r
vmodel provides an explanation rooted entirely in the dy-
namics: sog and dpp mutations have opposite effects h
2on the timing of the above-mentioned receptor occu-
pancy jump. Thus, part of the decrease in PMad stain-
ing at the dorsal midline of a dpp−/+ embryo is due to a D
delay in the onset of peak growth (i.e., the PMad peak
is less far along at the time point examined). Reduction D
din sog dosage has the countervailing effect of acceler-Figure 7. Reducing sog Gene Dosage Rescues Patterning Defects Caused by Reduced dpp Gene Dosage
(A) Predicted effects of decreasing the rate of BMP and Sog production on the formation of the embryonic BMP gradient. The highest and
lowest curves show that halving BMP synthesis is expected to reduce the midline accumulation of BMP-receptor complexes markedly. The
solid curve shows that additionally halving Sog production should be able to rescue, at least partially, the PMad distribution. Parameters
were as in Figure 5. Patterns shown are at 36 min after onset of BMP production.
(B–D) PMad staining of wild-type (B), dpp−/+ (C), and sog−/+; dpp−/+ (D) embryos (dorsal views). In a dpp−/+ embryo (C), PMad staining is
weaker and less regular than in wild-type. PMad staining in a sog−/+; dpp−/+ embryo (D) is stronger and more regular than in dpp−/+ single
mutants, although less regular than in wild-type embryos. Note also that the lateral expansion of PMad staining normally observed in sog−/+
embryos (Figure 2B) is not seen in sog−/+; dpp−/+, indicating that sog and dpp exert opposing gene dosage effects that approximately cancel
each other out in the double mutant condition. The embryos in (B)–(D) were stained in parallel, and the data were collected using the same
confocal scanning settings. The embryos shown are representative of at least 20 embryos of each genotype. These results agree with earlier
data showing that dpp−/+ embryos exhibit a nearly complete loss of race expression posterior to eve-st2 (Rusch and Levine, 1997) and that
sog−/+; dpp−/+ transheterozygotes exhibit a w50-fold increase in viability when compared to dpp−/+ embryos (Francois et al., 1994).ating peak growth (see Supplemental Data), compen-ating, in the short term, for the effects of reduced
pp expression.
A third important feature of the model is that it pre-
icts that Dpp’s range of action should be greater in
he presence of Sog than in its absence, even though
og has no effect on the diffusion of Dpp. An example
f this effect can be seen in the comparison of Figure
D with 2F, which shows clearly that st2-Dpp acts at a
reater distance in sog+ than in sog− embryos. It is easy
o see how such data could lead one to conclude that
pp diffuses faster in the presence of Sog (Eldar et al.,
002; Wang and Ferguson, 2005), but the model ex-
lains that such an inference (which is biochemically
roblematic, anyway) is not needed. The observed
ehavior can arise simply by virtue of the fact that
og protects Dpp from receptor-mediated degradation,
uch degradation being rapid enough to keep its range
f action otherwise fairly short. This range-enhancing
ffect of Sog is a generic one that any soluble inhibitor,
t moderate concentrations, should have on a diffusible
orphogen; it does not require Tld and is not the same
s the shuttling mechanism that concentrates BMPs at
he dorsal midline (see Supplemental Data). Clearly,
here are multiple ways in which soluble inhibitors can
edistribute morphogens, a point that may be of rele-
ance in other morphogen systems where soluble in-
ibitors are expressed (e.g., Balemans and Van Hul,
002; Kawano and Kypta, 2003).
iscussion
orsoventral patterning of the Drosophila ectoderm is
riven by a morphogen gradient that is distinctive in atleast three regards: it forms and acts quickly; it has an
Origin of a BMP Activity Gradient
921unusual profile, with a sharp peak at the dorsal midline;
and it relies upon the activities of at least three nonsig-
naling, secreted proteins (Sog, Tsg, and Tld). The goal
of the present study was to reveal how these character-
istics—dynamics, shape, and protein-protein interac-
tions—depend on each other.
We began by showing that robustness with respect
to variations in the expression of single genes is not a
characteristic of this system (Figure 1). This is an im-
portant observation, given that considerable attention
has been focused lately on the robustness of morpho-
gen-patterning systems (Eldar et al., 2003; Houch-
mandzadeh et al., 2002; von Dassow et al., 2000), as
well as biological signaling in general (Alon et al., 1999;
Morohashi et al., 2002). The fact that sog−/+ embryos
eventually develop normally underscores the ability of
embryos to compensate at later stages for early errors
(cf. Houchmandzadeh et al., 2002). It is not clear why
marked effects of sog heterozygosity were not seen in
similar experiments by Eldar et al. (2002); this may have
been related to their inability to genotype individual em-
bryos, or to a lower sensitivity of PMad staining. We
note that recent observations on accumulation of the
co-smad Medea in wild-type and presumptive sog−/+
embryos (Sutherland et al., 2003) look very similar to
our observations on PMad in embryos of unambiguous
genotype (Figures 1A and 1B).
We next examined the diffusibility of BMPs in the
embryo in the presence and absence of Sog (Figures 2
and 3). Recently, Eldar et al. (2002) asserted that BMPs
are effectively indiffusible in the embryo, except when
complexed with Sog. In contrast, by examining em-
bryos in which Dpp was ectopically expressed, we ob-
served that the range of Dpp action was reduced in the
absence of Sog, but still substantial, and consistent
with unhindered diffusion. By observing the rate at
which continuous ectopic Dpp expression gave rise to
an unchanging response profile, we were also able to
infer that Dpp must undergo rapid degradation, pre-
sumably through receptor-dependent means. In these
experiments, levels of expression of ectopic Dpp were
not high (2.5-fold above normal when two copies of st2-
dpp were present, as in Figure 2; presumably only
slightly above normal when one copy was present, as
in Figure 3). It should also be noted that these results
cannot be accounted for by the fact that Eve2 expres-
sion is weakly observed in a wider domain at its onset
(Small et al., 1992), for several reasons. First, the rapid-
ity with which early PMad signals are lost in the embryo
(e.g., in lateral portions of the dorsal ectoderm) implies
that there should be little perdurance of BMP signaling
over the time course of the experiments in Figures 2
and 3. Second, the rapidity of Dpp degradation sug-
gests that there should be little perdurance of Dpp-
receptor complexes. Finally, it is clear that the range
of Dpp action in Figure 2D extends more than two
eve stripes past eve-st2 and continues to build pro-
gressively even after eve-st2 has fully refined to a nar-
row stripe.
We utilized the above observations to produce a sim-
plified model of gradient formation. Our goal was not
necessarily to reproduce all aspects of the in vivo gra-
dient, but rather to begin with a minimum number of
elements—and as few assumptions as possible—and
then ask which of the behaviors of the in vivo gradientcould be captured. Interestingly, a great many of those
behaviors emerge from a model in which a single ligand
(e.g., Dpp or a Dpp/Scw heterodimer) diffuses freely, is
degraded by receptors, forms a complex with Sog and
Tsg, and is released from that complex when Tld
cleaves Sog. These behaviors include rapid dynamics,
formation of a broad domain of weak dorsal signaling
that abruptly refines to a sharp midline peak, and peak
narrowing or broadening when sog dosage is either in-
creased or decreased, respectively (Figures 5 and 6).
These behaviors depend upon the combined presence
of Sog, Tsg, and Tld and are also highly sensitive to
dpp dosage (in agreement with Dorfman and Shilo,
2001; Rusch and Levine, 1997; Sutherland et al., 2003).
Interestingly, highly localized expression of Tld and an
absolute dependence of Sog cleavage on Dpp are not
essential (data not shown). Also not critical is the order
of assembly of Dpp-Sog-Tld complexes.
Although the ability of the model to form a midline
peak of BMP activity exemplifies the Sog/Tld-depen-
dent “shuttling” proposed by others (Holley et al., 1996;
Ross et al., 2001; Shimmi and O’Connor, 2003), that
mechanism does not give a complete picture of events.
For one thing, the abrupt onset of midline peak growth
after a substantial plateau phase reflects a BMP-cata-
lyzed chain reaction of Sog destruction that is indepen-
dent of BMP transport per se. Second, calculations
show that any soluble inhibitor has the ability to expand
the range of action of a morphogen simply by protect-
ing it from receptor-mediated destruction. Indeed, this
effect alone could underlie some of the greater range of
action of ectopically expressed Dpp in wild-type versus
sog− embryos.
At least one feature of the model that does not match
in vivo observations, even when investigated over a
wide range of parameter values, is the magnitude of
the effect of sog heterozygosity on PMad peak width.
Figure 1 suggests a near doubling of peak width, whereas
calculations predict a more modest increase (Figure 6).
Even accounting for the nonlinearity of immunohisto-
chemistry and the fact that PMad may not be an in-
stantaneous read-out of BMP receptor occupancy, the
data suggest that other processes, not captured in the
simple model, regulate the shape of PMad peaks. For
example, it might be necessary to include the effects
of a novel truncated form of Sog that promotes, rather
than inhibits, BMP signaling (Yu et al., 2004).
One process that seems especially likely to shape
PMad peaks is a BMP-driven, transcription-dependent
feedback loop that has very recently been shown to
markedly amplify high and depress low levels of BMP
signaling in the Drosophila embryo (Wang and Fergu-
son, 2005). Such feedback could not only modify the
shapes of PMad peaks, but also potentially explain an-
other peculiarity of the model, which is that its peak
heights and widths best fit mutant data when they are
looked at up to the 30–45 min period, but not much
later (i.e., not in the mathematical steady state). Since
positive-feedback regulation of BMP signaling (Wang
and Ferguson, 2005) can be expected to both sharpen
and maintain patterns that might otherwise have con-
tinued to evolve, it is perhaps not surprising that, at
long enough times, in vivo behavior diverges from pre-
dictions of the model. Put another way, this issue
serves as a reminder that, unlike BMP gradients at lar-
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ainal discs), the embryonic BMP gradient forms and acts
aso rapidly that there is little justification for assuming
w
that steady-state calculations should reproduce in vivo t
observations. Indeed, it is only by considering the dy- a
Dnamics of gradient formation that the model presented
nhere is able to explain the seemingly paradoxical result
fthat decreased dorsal midline PMad staining in dpp−/+
sembryos can be rescued by lowered sog dosage (Fig-
l
ure 7), when loss of sog function, by itself, is associated
with decreased dorsal midline PMad staining. I
In summary, the results presented here indicate that E
aknown properties of the molecules required for forma-
ntion of the Drosophila embryonic BMP gradient are suf-
wficient to account for many aspects of gradient dy-
e
namics, shape, and robustness, with no need for t
assumptions such as lack of diffusion of free BMP, tran- d
sient BMP synthesis, removal of BMP from its recep- r
gtors by Sog, or attainment of a steady state. Although
3computational data indicate that a Sog/Tld-dependent
rshuttling mechanism plays a key role in shaping and
a
timing this BMP gradient, other dynamic processes ap-
pear to participate as well. C
S
eExperimental Procedures
o
bDrosophila Stocks and Genetic Crosses
oThe following stocks were used: Canton-S and w (used as wild-
atype background), sog6/C(1)RM, y w f/Dp(1;Y)y+ sog+ BS, gd7
sogU2/FM7, gd7/FM7; D/TM3 Sb, mwh[1] snk[1] red[1] e[1] Tl[3]
ca[1]/ TM3, Sb/Ms(3)R24, y w; st2-dpp (a gift from H. Ashe), and w
SsogU2/FM7; st2-dpp. Description of mutations is found in Lindsley
and Zimm (1992) and Flybase (http://flybase.bio.indiana.edu). Ge-
Snotypes of sog−/+ heterozygote female and w/Dp(1;Y)y+ sog+ BS
mmale embryos resulting from the cross between sog6/Dp(1;Y)y+
hsog+ BS s males and w females were determined by the expression
of the Sex lethal, a female-specific protein. The same method was
Aused to identify C(1)RM y w/Dp(1:Y) y+ sog+ BS female embryos
with extra copy of sog, collected from the sog6/C(1)RM, y w
Wf/Dp(1;Y)y+ sog+ BS stock. To create lateralized embryos with st2-
idpp (Figure 3), gd7 sogU2/gd7; mwh[1] snk[1] red[1] e[1] Tl[3] ca[1]/+
bfemales were crossed to yw; st2-dpp/st2-dpp males. For scoring
fsog− embryos in Figures 2E, 2F, and 3B, a sog in situ probe was
tused in addition to discriminate embryos that lack sog expression.
PEmbryo collections were performed at 25°C.
(For the analysis of dpp and sog gene dosage, we used the
dppH46 Sp/CyO23, Df(2L) DTD48/CyO23, and sog6/Dp(1;Y) y+ BS
sog+ stocks. dpp−/+ heterozygotes were generated by crossing R
Df(2L)DTD48/CyO23 flies to w- and scoring the progeny for PMad R
staining, which fell into two clearly distinguishable classes: 3× dpp, A
very strong staining; and 1× dpp, weak staining. Double heterozy- P
gous sog−/+; dpp−/+ embryos were generated by crossing dppH46
Sp/CyO23 females to sog6/Dp(1;Y) y+ BS sog+ males and screening R
female embryos expressing Sxl and scored for PMad staining. These
embryos also fell into two clearly distinct categories: sog6/+; +/CyO23
A
(1× sog; 3× dpp = very strong and broad PMad staining) and the
n
double heterozygotes, sog6/+; dppH46/+ (1× sog; 1× dpp = approxi-
Amately wild-type level of PMad staining with some irregularity in
epattern).
r
e
Immunofluorescence and In Situ Hybridization
A
A detailed description of fluorescent methods used to detect multi-
g
ple RNA transcripts is given in Kosman et al. (2004). Probes were
Alabeled with digoxigenin, biotin, fluorescein (Roche), and dinitro-
ephenol (NEN) haptens. For double protein detection and in situ
4staining, fixed embryos were treated with acetone (10 min at −20°C)
before hybridization to allow penetration of probes, as a substitute A
tfor proteinase K incubation (Nagaso et al., 2001). After this treat-
ment, in situ hybridization was performed before immunostaining oith rabbit anti-phosphoMAD (1:2000, a gift from P. ten Dijke) and
ntibodies to detect the RNA-labeled probes. Detection of primary
ntibodies was performed either with secondary antibodies labeled
ith Alexa Fluor dyes (used at 1:500, Molecular Probes) or using
he Zenon kit (Molecular Probes). For a list of primary and second-
ry antibodies used, see Kosman et al. (2004), and Supplemental
ata. Detection of Sex lethal protein was done with M18 monoclo-
al antibody (used at 1:1000, Iowa Hybridoma Bank). Images of
luorescently labeled embryos were acquired on a Leica SP2-AOBS
canning confocal microscope with 20× and/or 40× objective
enses.
ntensity Measurement of Dpp RNA
mbryos carrying two copies of st2-dpp were labeled with a probe
gainst Dpp RNA, and fluorescent signals were captured in a scan-
ing Confocal series. Image stacks were analyzed using Leica soft-
are. Different “regions of interest” of equal area were selected in
ach of three areas of the embryo: within the st2-dpp stripe ven-
rally (1), outside of the st2-dpp stripe but within the dorsal ecto-
erm in which endogenous dpp is expressed (2), and in the ventral
egion of the embryo where no dpp is expressed (3, residual back-
round of staining). Corrected intensity values for st2-dpp (1 minus
) and endogenous dpp (2 minus 3) mRNA were computed and the
atio of st2-dpp and endogenous dpp intensities were calculated
nd averaged for five late blastoderm-stage embryos.
omputational Methods
ystems of equations were solved numerically using finite differ-
nce schemes. Diffusion terms were approximated by the second-
rder central difference, and temporal evolution was approximated
y a fourth-order Adams-Moulton predictor-corrector method. The
verall accuracy of the implementation is second-order in space
nd fourth-order in time.
upplemental Data
upplemental Data include 12 figures and Supplemental Experi-
ental Procedures and can be found with this article online at
ttp://www.developmentalcell.com/cgi/content/full/8/6/915/DC1/.
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